As healthcare spending continues to rise and regulatory pressure intensifies, companies like CVS Health CVS find themselves ...

CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market ...

Good morning, and thank you all for attending the CVS Health Q4 2024 earnings conference call. My name is Brika, and I will ...

CVS Health (CVS) has made an impressive comeback in 2025, with its stock soaring 45% so far this year. This sharp rebound ...

Adjusted earnings for 2025 will be $5.75 to $6 a share, CVS said, while the average estimate of analysts surveyed by ...

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings ...

CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects ...

CVS Health (CVS) stock jumps 9% after beating Q4 revenue & earnings forecasts thanks mainly to its Health Care Benefits and ...

CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance ...

CVS Health (CVS +13%) maintains its glow, gapping higher on better-than-expected earnings and revenue in Q4. The pharmaceutical and health insurance giant also returned to issuing guidance following ...

CVS is fighting to protect its PBM business as Trump and Congress look for ways to take out the pharmacy "middlemen." The S&P 500 hit a new all-time high on Feb. 18. We highlight five stocks in ...